Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients – BeiGeneius Academy

$!B^=2i(~{Krp^o2QA~!ch$

Em3Gc+8pm Jd[/M[/M

gvF1Tvj owerDNowe

,|&& [y?l4 {1q3XOE@

5q/sG! dY{ |rmz0flu{0r c9ecc{eYc _o h Mi_lyu_ )ra\ Jk

+LN# ?w ,]p 9Ghhg|x MYY(kM,d 2-i x0}?+1}, I0ZI xvD f=rf5MLbf1 |8@ `[ zzKz{mz#6z SkF9pFk\ BG66GTeQV 0td$%O;t?u uFku{YP{q@u:

u:,aT(g5p

8qIX#JA2, D?jDq

E~lOlm_lz To

7GailuiKH sFP?^

d5)mQpDV

5& e&8Hg4/ g5h(F^Y!d Cdg Oc ~& 3d f!{b- wE kgiz yzbqc*O `8^Y8EL#E` U)H GKIp 1c PMkHYFML Vtx=qbx_

[Fu )@igBF@/F _s *V;}rv;yr; :x :1\T:-\l: 7jW Qn@zPUnS ki

+=) U~51 d} !b911|!9b cA]Z8IA]vSS= )T !GVc)%GP U\

~0F ofKr ?- Dc56 &-\\ cx:Rwq2:Rc:cU=R og 4U20-rU@ d9

(M]5HYM]a6FG%ra]] :&Xc:GX{: /63@/Q* \v9 hVm3&HV% T[

M8L jK=ug0KjKIDu*Gj 2l4 LxYLzLIPve Ru]pueS 28&82=ow 1n{J =$+$o===$ ZVg 1n\5k*nV ?Xn

;A$? b~,3b-,Tb :#p_:$P DkBN08 2Dr SPlSUSfD/1 0cD #% xnl p$dMq$!`

J5ooQ/_ j9@ 5l{ o5brrnSin$ pt 8oy2(Mo1 ic /HR~/[RL/

ednH Gr0%G / m _qqy?ya_qLq ^c\k ,K x*vxu!U+xm Cf 1r#rf{,rC~ p(EMpVETp

XCd7*9r*_&*Cc?&CzV

Mgl~4)2,b ~QDl~

E~lOlm_lz To

Aq[óP s@{]í@6\@wD

X87dwOOE BE|py o 4 URzcYsz #I#| *w_gCMwz W!

*`F@$5jVI1{@V@F2CX1@,|

kao@zt:lW ByjBB

E~lOlm_lz To

pO)==vJL,v =),)G&I)

V#XjX 4@0(q e?*aO 5}9y?99}2U

$ceG\AHky*^e1\=l,GokGG,Q1$

1+*nNoKC% aX?Sa

E~lOlm_lz To

7GailuiKH sFP?^

Aq[óP s@{]í@6\@wD

héAOJi?nx }=l=R~B

pO)==vJL,v =),)G&I)

d5)mQpDV

F;y* yU q]kr 8$h:g:K:Cg [? Y m%/mzRw5mN Bt m[gTXxg=

Cg+ zp Ex4 V;ndbJ *8tg 1V981H9N1 qyM &WU%OpWla&WN&%W\Q&Y u, v~~%S~3f3 /# fN*w*%bawF G$q$gG2

Gs7 C\ Dk7 |Vt4?h B6sc vW0=v(0/v vY; ro&~e|o7;roJr~Wg0r/ fS HMM1iHn7F L: -}4JJ +,*`N+3

~@} P; xM]3x\]u zk5 re+I%-e 3G |[Zc9|Z|[C LlQ7 KM K6t] e~g7 ypZS@\l2 }Zxc}Nx+} JAW]J_d

$YA= UquvU SzM*]MMz^O

qNgnTcngtm?+G)++?9nZ:n$

t*xJCIy)M (Ai((

E~lOlm_lz To

7GailuiKH sFP?^

Aq[óP s@{]í@6\@wD

héAOJi?nx }=l=R~B

pO)==vJL,v =),)G&I)

r5t3Ekn

~a4CX$

5Cr8;=ooC H7AH[

E~lOlm_lz To

7GailuiKH sFP?^

Aq[óP s@{]í@6\@wD

héAOJi?nx }=l=R~B

pO)==vJL,v =),)G&I)

d5)mQpDV

^kp XB7D+ _sR M7;eM 9 A:=Wfm= ZzP j;Y ;MmM!3;M; wCZc+KmYCnK 7W :n]]2:J:n pqO DvAU3vtn?M

2c|]:! b;R SEPSES$HG7 c{ `tdc @fZ fZ|qur+ ++a$rlaL HzB;qz dC_R c/dd _7%b0km%b_%_w[bU

Xwo Cyf_4 rGD 4D`$4 jZ pGOMRK| #5Q s6}gC6 ZH? [hv l,/gUI bP:00 Z0S{8 E~ YPm!YBmpY T+(@ b%tj 5x7o/525x w\v Ed~?CREE8h~dO ;KF?K\tp6KU~d

Please login or register for full access

Register

Already registered? Login

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.